"Cholinergic Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
Descriptor ID |
D018680
|
MeSH Number(s) |
D27.505.519.625.120.200 D27.505.696.577.120.200
|
Concept/Terms |
Cholinergic Antagonists- Cholinergic Antagonists
- Antagonists, Cholinergic
- Cholinergic Antagonist
- Antagonist, Cholinergic
- Cholinergic-Blocking Agents
- Agents, Cholinergic-Blocking
- Cholinergic Blocking Agents
- Cholinolytics
- Acetylcholine Antagonists
- Antagonists, Acetylcholine
- Cholinergic Receptor Antagonists
- Antagonists, Cholinergic Receptor
- Receptor Antagonists, Cholinergic
Anticholinergic Agents- Anticholinergic Agents
- Agents, Anticholinergic
- Anticholinergics
- Anti-Cholinergics
- Anti Cholinergics
|
Below are MeSH descriptors whose meaning is more general than "Cholinergic Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Cholinergic Antagonists".
This graph shows the total number of publications written about "Cholinergic Antagonists" by people in this website by year, and whether "Cholinergic Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2006 | 2 | 0 | 2 |
2007 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2017 | 9 | 2 | 11 |
2018 | 16 | 1 | 17 |
2019 | 3 | 1 | 4 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cholinergic Antagonists" by people in Profiles.
-
Anticholinergic drugs versus preprocedural mouth rinses for reduction of SARS-CoV-2 load in dental aerosols. Med Hypotheses. 2021 05; 150:110577.
-
Taking care of continence patients during the COVID-19 pandemic. Br J Nurs. 2020 Dec 10; 29(22):1318-1324.
-
Drug Burden Index and Its Association With Hip Fracture Among Older Adults: A National Population-Based Study. J Gerontol A Biol Sci Med Sci. 2019 06 18; 74(7):1127-1133.
-
Novel eugenol bearing oxypropanolamines: Synthesis, characterization, antibacterial, antidiabetic, and anticholinergic potentials. Bioorg Chem. 2019 07; 88:102931.
-
Effects of baseline symptom burden on treatment response in COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:181-194.
-
The Treatment of Primary Focal Hyperhidrosis Skin Therapy Lett. 2019 01; 24(1):1-7.
-
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis. Eur Respir J. 2018 12; 52(6).
-
Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide as a combination therapy for chronic obstructive pulmonary disease. Expert Rev Respir Med. 2019 01; 13(1):5-11.
-
The excess mortality risk associated with anticholinergic burden among older patients discharged from acute care hospital with depressive symptoms. Eur J Intern Med. 2019 03; 61:69-74.
-
Anti-cholinergic burden and patient related clinical outcomes in an emergency general surgical setting. Asian J Surg. 2019 Apr; 42(4):527-534.